Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §5

CEI-MS-04 — system suitability and acceptance criteria

The performance the system must demonstrate, and the criteria a result must meet to be reportable.

Document identifier
CEI-MS-04/5
Series
Methodological standard
Version
1.2
Published
23 May 2024
Last reviewed
23 May 2025
Next review
23 May 2028
Identifier
10.71829/cei.meth.4
Certainty
High
Cycle
2024 Q2
Category
Content

§5System suitability and acceptance criteria

§5.1System suitability

Table 1. System suitability criteria. A determination is reportable only where every criterion is met at the time of analysis.

ParameterCriterionWhat it establishes
Cell drift before titration≤ 20 µg/minCell dryness
Water-standard recovery97.5–102.5 %System accuracy
Relative standard deviation, three determinations≤ 5 %Repeatability
Sample mass5–20 mgAdequate titre against blank

§5.2Acceptance criteria

  • Water content is reported as determined. The Institute sets no universal limit, but records that a lyophilised peptide with water above approximately 10 % should be regarded as having a materially shortened solid-state shelf life because residual water mobilises deamidation and aspartimide formation.
  • A determination without a reported cell drift and standard recovery is not reportable.

§5.3Limitations

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.